For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Dexcom ONE (Real-time continuous glucose monitoring) - Type II Diabetes (Adults)
PAD Profile : Dexcom ONE (Real-time continuous glucose monitoring) - Type II Diabetes (Adults)
Traffic Light Status
Status 1 of 1.
- Device
Guidelines
No guidelines returned.
Other Drugs
- FreeStyle Libre 2 (Intermittently scanned continuous glucose monitoring)
- Freestyle Libre 2 Plus (Real-time continuous glucose monitoring)
- Dexcom ONE Plus (Real - Time Continuous Glucose Monitoring)
- FreeStyle Libre 3 (real-time continuous glucose monitoring)
- GlucoRx Aidex (Real-time continuous glucose monitoring)
- A8 Touchcare Nano (Real-time continuous glucose monitoring)
- Dexcom 7 (Real-time continuous glucose monitoring)
- Dexcom 6 (Real-time continuous glucose monitoring)
- Medtronic Guardian 3 (Real-time continuous glucose monitoring)
- Medtronic Guardian 4 (Real-time continuous glucose monitoring)
- Continuous Glucose Monitoring
Other Indications
- Type 2 Diabetes (Children and Young People)
- Congenital hyperinsulinism
- Type 2 Diabetes (Children and Young People)
- Type 2 Diabetes (Children and Young People)
- Type 2 Diabetes (Children and Young People)
- Type 2 Diabetes (Children and Young People)
- Type 2 Diabetes (Children and Young People)
- Type 2 Diabetes (Children and Young People)
- Type 2 Diabetes (Children and Young People)
- Type 2 Diabetes (Children and Young People)
- Type 1 Diabetes
- Type 1 Diabetes
- Type 2 Diabetes (Children and Young People)
- Type 2 Diabetes (Adults)
- Type 2 Diabetes (Adults)
- Type 2 Diabetes (Adults)
- Type 2 Diabetes (Adults)
- Type 2 Diabetes (Adults)
- Type 2 Diabetes (Adults)
- Type 2 Diabetes (Adults)
- Type 2 Diabetes (Adults)
- Type 2 Diabetes (Adults)
- Type 2 Diabetes (Adults)
Additional Documents
No additional documents returned.
Committee Recommendations
In line with NICE NG28 (Type 2 diabetes in adults: management – Continuous Glucose Monitoring – last updated June 2022), Dexcom ONE is agreed for use in adult patients with type 2 diabetes.
Dexcom ONE for this indication will be considered as GREEN on the traffic light system, as follows:
1. are on multiple daily insulin injections (> 1x a day insulin dose) if any of the following apply:
- they have recurrent hypoglycaemia or severe hypoglycaemia.
- they have impaired hypoglycaemia awareness (Gold/Clarke score ≥4)*
- they have a condition or disability (including a learning disability or cognitive impairment) that means they cannot self-monitor their blood glucose by capillary blood glucose monitoring but could use an isCGM device (or have it scanned for them)
- they would otherwise be advised to self-measure at least 8 times a day
2. are treated with insulin and who would otherwise need help from a care worker or healthcare professional to monitor their blood glucose.
3. have learning disabilities and are on the learning disability register and using insulin. (as per previous Surrey Guidance)
4. are pregnant and having difficulty managing their glucose levels.